Baseline left atrial volume as a potential predictor of trastuzumab related cardiotoxicity in her 2 positive breast cancer patients

被引：0
|
作者：
Dolci, G. [1 ]
Bergamini, C. [1 ]
Benfari, G. [1 ]
Torelli, F. [1 ]
Ghiselli, L. [1 ]
Rossi, A. [1 ]
Trevisani, L. [1 ]
Truong, S. [1 ]
Vinco, G. [1 ]
La Russa, F. [2 ]
Molino, A. [2 ]
Vassanelli, C. [1 ]
机构：
[1] Univ Verona, Sect Cardiol, Dept Med, Verona, Italy
[2] Civil Hosp Maggiore Borgo Trento, Oncol, Verona, Italy
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P569
引用
收藏
页码：99 / 99
页数：1
相关论文
共 50 条
  • [31] SURVIVAL AND CARDIOTOXICITY FOR PATIENTS WITH HER2 POSITIVE, METASTATIC BREAST CANCER TREATED WITH TRASTUZUMAB IN ROUTINE CLINICAL PRACTICE
    Vasista, Anuradha
    Ryan, Luke
    Wilcken, Nicholas
    Moylan, Eugene
    Stockler, Martin
    Kiely, Belinda
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 146 - 147
  • [32] The influence of steroid receptor status on the cardiotoxicity risk in HER2-positive breast cancer patients receiving trastuzumab
    Huszno, Joanna
    Badora, Agnieszka
    Nowara, Elzbieta
    ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (02) : 371 - 377
  • [33] Delta NT-proBNP predicts cardiotoxicity in HER2-positive breast cancer patients treated with trastuzumab
    Andersson, Anton E.
    Linderholm, Barbro
    Giglio, Daniel
    ACTA ONCOLOGICA, 2021, 60 (04) : 475 - 481
  • [34] Trastuzumab cardiotoxicity in HER2-positive breast cancer patients in tertiary health care center, sultanate of Oman
    Abd Alghafar, Doaa
    Younos, Ibrahim
    Al Baimani, Khalid
    Al-Salhi, Dawood
    Al-Riyami, Adil
    Rizvi, Syed
    Buckley, Niamh E.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (02) : 312 - 321
  • [35] Cardiotoxicity associated with trastuzumab treatment of HER2+ breast cancer
    Fiúza M.
    Advances in Therapy, 2009, 26 (Suppl 1) : S9 - S17
  • [36] Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer
    Anthony F. Yu
    Nandini U. Yadav
    Betty Y. Lung
    Anne A. Eaton
    Howard T. Thaler
    Clifford A. Hudis
    Chau T. Dang
    Richard M. Steingart
    Breast Cancer Research and Treatment, 2015, 149 : 489 - 495
  • [37] A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer
    Ben Kridis, Wala
    Sghaier, Syrine
    Charfeddine, Salma
    Toumi, Nabil
    Daoud, Jamel
    Kammoun, Samir
    Khanfir, Afef
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (07): : 510 - 516
  • [38] Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer
    Yu, Anthony F.
    Yadav, Nandini U.
    Lung, Betty Y.
    Eaton, Anne A.
    Thaler, Howard T.
    Hudis, Clifford A.
    Dang, Chau T.
    Steingart, Richard M.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 149 (02) : 489 - 495
  • [39] The Research Progress of Trastuzumab-Induced Cardiotoxicity in HER-2-Positive Breast Cancer Treatment
    Lin, Mengmeng
    Xiong, Weiping
    Wang, Shiyuan
    Li, Yingying
    Hou, Chunying
    Li, Chunyu
    Li, Guohui
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 8
  • [40] Trastuzumab interruption for treatment-induced cardiotoxicity in HER2 positive early breast cancer
    Yu, Anthony F.
    Yadav, Nandini U.
    Lung, Betty Y.
    Eaton, Anne A.
    Thaler, Howard T.
    Hudis, Clifford A.
    Dang, Chau T.
    Steingart, Richard M.
    CANCER RESEARCH, 2015, 75
12345